Antibody response to SARS‐CoV‐2 vaccination is extremely vivacious in subjects with previous SARS‐CoV‐2 infection

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic calls for rapid actions, now principally oriented to a world‐wide vaccination campaign. In this study we verified if, in individuals with a previous SARS‐CoV‐2 infection, a single dose of messenger RNA (mRNA) vaccine would be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Med Virol
Autors principals: Callegaro, Annapaola, Borleri, Daniela, Farina, Claudio, Napolitano, Gavino, Valenti, Daniela, Rizzi, Marco, Maggiolo, Franco
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Short Communications
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250392/
https://ncbi.nlm.nih.gov/pubmed/33788281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26982
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars